5th International Workshop on Chronic Lymphocytic Leukemia

Leuk Res. 1992 Jun-Jul;16(6-7):717-20. doi: 10.1016/0145-2126(92)90023-z.

Abstract

In the past few years important advances have been made in our understanding of the biology and natural history of CLL; also, new strategies and agents offer promise in the treatment of this form of leukemia. Now, patients can be treated on a more rationale basis and with real prospects for a sustained control of their disease, and improved quality of life. Hopefully, progresses in CLL will continue to accumulate in the coming years.

Publication types

  • Congress
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow Transplantation
  • Gene Rearrangement, B-Lymphocyte
  • Growth Substances / metabolism
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell* / metabolism
  • Leukemia, Lymphocytic, Chronic, B-Cell* / pathology
  • Leukemia, Lymphocytic, Chronic, B-Cell* / therapy
  • Mice
  • Prognosis

Substances

  • Growth Substances